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Abstract
Objective: The present study aimed to examine the association between maternal passive smoking during pregnancy and
the risk of spontaneous PTD and to explore the potential interaction of the single or joint gene polymorphism of CYP1A1
and GSTs with maternal passive smoking on the risk of spontaneous PTD.
Method: We investigated whether the association between maternal passive smoking and PTD can be modified by 2
metabolic genes, i.e. cytochrome P4501A1 (CYP1A1) and glutathione S-transferases (GSTs), in a case-control study with 198
spontaneous preterm and 524 term deliveries in Shenzhen and Foshan, China. We used logistic regression to test gene-
passive smoking interaction, adjusting for maternal socio-demographics and prepregnancy body mass index.
Results: Overall, maternal passive smoking during pregnancy was associated with higher risk of PTD (adjusted odds
ratio=2.20 [95% confidence interval: 1.56–3.12]). This association was modified by CYP1A1 and GSTs together, but not by
any single genotype. For cross-categories of CYP1A1 Msp I and GSTs, maternal passive smoking was associated with higher
risk of PTD among those women with CYP1A1 ‘‘TC/CC’’+ GSTs ‘‘null’’, but not among women with other genotypes; and this
interaction was significant (OR=2.66 [95% CI: 1.19–5.97]; P-value: 0.017). For cross-categories of CYP1A1 BsrD I and GSTs,
maternal passive smoking was associated with higher risk of PTD only among those women with CYP1A1‘‘AG/GG’’+ GSTs
‘‘null’’, but not among women with other genotypes; and this interaction was significant (OR=3.00 [95% CI: 1.17–7.74]; P-
value: 0.023).
Conclusions: Our findings suggest that the combined genotypes of CYP1A1 and GSTs can help to identify vulnerable
pregnant women who are subject to high risk of spontaneous PTD due to passive smoking.
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Introduction
Preterm delivery (PTD, ,37 completed weeks of gestation) is a
big clinical and public health challenge globally. Despite increased
awareness and improved prenatal care, the percentage of PTD
remains unacceptably high in both developed (e.g. 7% in U.S. [1])
and developing societies (e.g. 5–15% in China [2]). About 15%
preterm babies die within one month after birth [3]. PTD also
leads to many other short- and long-term health problems and
poses enormous burden to both health care system and the child’s
family [4]. Preterm delivery is often classified into spontaneous and
medically indicated subgroups, and the majorities (75–85%) of
PTDs are spontaneous [5]. The causes and underlying biological
mechanisms of spontaneous PTD are still unclear [6], although
previous studies have identified a long list of risk factors, including
low socio-economic status [7], parity, maternal age [8], drug
abuse, life events [9], racial origin [10], maternal active or passive
smoking [11], air pollution [12,13] intrauterine infection [14], and
genetic heterogeneity [9,15].
Maternal active smoking is a well-established risk factor for
PTD, and it accounts for about 14% of all PTDs [16]. But only a
relatively small proportion of smoking pregnant women end with
PTD, which may be explained by the substantial variability in
genetic susceptibility across individuals. Some evidences show that
gene polymorphism in cytochrome P4501A1 (CYP1A1) and
glutathione S-transferases (GSTs) may modify the link between
maternal active smoking and PTD [17]. CYP1A1 is one of
cytochrome P450 (CYP450) family genes that are responsible for
phase I detoxication by converting exogenous exposures, e.g.
tobacco compounds, into intermediate metabolites. CYP1A1
mutation can lead to higher enzyme activity. GSTs are one of
PLOS ONE | www.plosone.org 1 November 2012 | Volume 7 | Issue 11 | e49155phase II detoxication enzymes that protect cells from toxicants by
conjugation with glutathione. Inherited homozygous deletion of
GSTs genes can result in lack of phase II detoxification activity
[18,19,20], which thus increases the accumulation of intermediate
metabolites of exogenous in human body. Limited researches
focused on the gene (CYP1A1, GSTs)-maternal active smoking on
the risk PTD yielded inconsistent findings [17,21,22].
Passive smoking is one of the most important public health
problems in many developing countries, such as China, where
many non-smoking pregnant women are exposed to environmen-
tal tobacco smoke at home, workplace, and public places [23].
Perera et al. found the levels of serum cotinine and DNA adducts
in passive smoking mothers were significantly higher than those in
non-passive smoking mothers [24]. Some previous studies, all done
in developed countries, suggest that maternal passive smoking may
shorten gestational age and thus increase the risk of PTD [23]. It is
unclear whether this association holds in pregnant women in
developing countries. Moreover, little is known about the potential
interaction between maternal passive smoking and genes
(CYP1A1, GSTs) polymorphisms in the risk of PTD.
Therefore, the present study aimed to fill these important
research gaps in this filed. Specially, we had 2 objectives in this
study: 1) to examine the association between maternal passive
smoking during pregnancy and the risk of spontaneous PTD
among Chinese pregnant women; 2) to explore the potential
interaction between the single or joint gene polymorphism of
CYP1A1 and GSTs with maternal passive smoking on the risk of
spontaneous PTD.
Materials and Methods
Study Population
We conducted a case-control study from September 2009 to
March 2011 at two Women and Children’s Hospitals at Shenzhen
and Foshan, Guangdong Province, China. Figure 1 shows the flow
chart of our study participants flowchart was listed in figure 1. A
total of 379 preterm (gestational age ,37 full weeks) babies were
born in these two hospitals during the study period. Among them,
223 spontaneous singleton babies were eligible for this study (see
below). Finally, 198 (88.8%) mothers of 223 eligible babies agreed
to participate in the study and were included as cases. We
randomly selected controls from those mothers who delivered term
singleton babies (gestational age 37–42 full weeks) with normal
birth weight (2500–4000 g) in the same hospital. To increase the
comparability, we matched 563 eligible controls with eligible cases
by delivery date (+/23 days). Among them, 524 (93.1%) mothers
of the controls agreed to participate in this study. We approached
participating mothers within 12–36 hours after delivery.
For the purpose of this study, we excluded the preterm babies
whose mothers: 1) actively smoked cigarettes during pregnancy
(n=2); 2) had one or more pre-existing chronic conditions,
including heart failure, chronic renal diseases, lung diseases,
diabetes, hypertension, hyperthyroidism, Mediterranean anemia
etc. (n=24); 3) had induced or accidental abortion (n=23); 4) had
multiple births or newborns with birth defects (n=32); or 5) had
medically indicated PTD due to obstetric complications, such as
severe preeclampsia, antepartum hemorrhage, placenta previa etc
(n=75).
All the participants understood and signed a written consent
form. This study was approved by the Ethics Committees of Sun
Yat-sen University in Guangzhou, China.
Data Collection
We collected data through interview, medical records review,
and blood lab tests. At the postnatal face-to-face interview, each
mother completed a structural questionnaire and reported her
passive smoking status during pregnancy, socio-demographics,
reproductive history, medical history, psychosocial stress, health
behavior and lifestyles. Pregnant women were expected to
complete up to 12 routine prenatal care visits for routine obstetric
examinations starting from the 20
th week of gestation: 2 visits
during 20–27 weeks of gestation, bi-weekly during 28–35 weeks of
gestation, and then weekly after 36 weeks of gestation. We
Figure 1. Flow chart of study participants.
doi:10.1371/journal.pone.0049155.g001
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medical records, including last menstrual period, ultrasound
assessment, maternal chronic diseases, and obstetric complica-
tions. We collected maternal blood samples within 12 hours after
admission to the hospital in tubes with anticoagulants (EDTA K2),
and then stored blood samples in a refrigerator at temperature of
280uC.
Measures
PTD outcome. Pregnant women self-reported their last
menstrual period (LMP) at the 1
st prenatal care visit (usually at
8–10
th week of gestation). The LMP was confirmed by early
ultrasound assessment (gestational age,20 full weeks). If self-
reported LMP was unavailable, ultrasound estimated LMP based
on the crown-rump length in early pregnancy was used instead
[25]. We calculated gestational age as the interval between LMP
and delivery date. We defined PTD as gestational age less than 37
complete weeks.
Passive smoking exposures. In this study, we measured
maternal passive smoking during pregnancy by combining self-
report and serum cotinine test. At the interview, participants
retrospectively self-reported their passive smoking status during
pregnancy.
We also measured the cotinine level in maternal peripheral
blood using enzyme immunoassay technique (Immunalysis Corp.,
Pomona, California, US; Manufacture-reported detection limit,
1 ng/ml). Briefly, we first added 10 ml of serum, calibrator, or
control to 3 separate assay wells, and mixed them with 100 mlo f
cotinine enzyme. Then we incubated these samples for 30 minutes
at room temperature, and washed the micro-plate 6 times with
350 ul buffer. Then we added 100 ml of substrate solution and
measured the absorbance spectrum of samples at 450 nm using a
micro-plate reader within 60 minutes.
We defined passive smoking as: 1) self-reported exposure to
cigarette smoke by others (at home, work or public places) during
pregnancy (n=199), or 2) serum cotinine level $3 ng/ml
(n=230). This combined use of self-report and serum cotinine
could reduce misclassification of passive smoking [26,27]. Overall,
there was relatively high concordance between self-reported
passive smoking when serum cotinine cut-off level was set as
3 ng/ml in our sample (Kappa-value: 0.752). However, 53 women
(7.3%) who did not report passive smoking but had serum cotinine
level $3 ng/ml and 22(3.0%) women who reported passive
smoking but had serum cotinine level ,3 ng/ml (Table S1).
Genotypes. We purified DNA from venous whole blood
samples using DNS purification kits (Takara, Biot. Ltd, China).We
used polymerase chain reaction (PCR) and restriction fragment
Table 1. Comparison of characteristics between spontaneous PTD cases and controls.
Cases (n=198) Controls(n=524) P-value
Mean ± SD or N. (%) Mean ± SD or N. (%)
Maternal age (years, mean 6 SD) 28.564.9 28.864.3 0.474
Marital status (%)
Married 193(97.5) 502(95.8) 0.290
Unmarried 5(2.5) 22(4.2)
Race/ethnicity (%)
Han 191(97.0) 507(96.9) 0.992
Minority 6(3.0) 16(3.1)
Education level (%)
Junior high school or lower 70(35.4) 136(26.0) 0.020
High school 55(27.8) 142(27.1)
College or higher 73(36.9) 246(46.9)
Family income (%)
Low 44(23.0) 141(27.2) 0.248
Middle 32(16.8) 102(19.7)
High 115(60.2) 276(53.2)
Parity (%)
Nullparous 134(67.7) 398(76.0) 0.024
Parous 64(32.3) 126(24.0)
Alcohol use during pregnancy, % 4(2.0) 17(3.2) 0.383
Prepregnancy BMI (kg/m
2)( % )
Underweight (,18.5) 45(22.7) 124(23.7) 0.606
Normal (18.5–23.9) 137(69.2) 346(66.0)
Overweight or obesity($24.0) 16(8.1) 54(10.3)
Child gender (%)
Male 109(35.6) 257(51.3) 0.105
Female 89(64.4) 271(48.7)
doi:10.1371/journal.pone.0049155.t001
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polymorphisms. We digested PCR products by Msp I (to identify
CYP1A1 m1 mutation) and BsrD I (to identify CYP1A1 m2
mutation) and then detected the genotypes of our interest,
including the homozygous wild type ‘‘TT’’ ‘‘AA’’, heterozygous
variant ‘‘TC’’ ‘‘AG’’, and homozygous variant ‘‘CC’’ ‘‘GG’’. The
PCR primers (Sangon biotech, shanghai, co., Ltd.) for CYP1A1
polymorphisms included Msp I forward 59-CAG TGA AGA GGT
GTA GCC GCT-39 and reverse 59-TAG GAG TCT TGT CTC
ATG CCT-39; BsrD I forward 59-CTG TCT CCC TCT GGT
TAC AGG AAG C-39 and reverse 59-TTC CAC CCG TTG
CAG CAG GAT AGC C-39. The PCR primers for GSTs
polymorphisms included GSTM1 forward 59-GAA CTC CCT
GAA AAG CTA AG-39 and reverse 59-GTT GGG CTC AAA
TAT ACG GTG G-39; and GSTT1 forward 59-TTC CTT ACT
GGT CCT CAC ATC TC-39 and reverse 59-TCA CCG GAT
CAT GGC CAG CA-39. As the internal control, a 268-bp
fragment of the human –b globin gene was coamplified with a
second set of primers (59-CAA CTT CAT CCA CGT TCA CC-
39) and (59-GAA GAG CCA AGG ACA GGT AC-39). Due to
small numbers of participants with homozygous variant genotypes,
we combined TC (n=310) and CC (n=127) as TC/CC, AG
(n=266) and GG (n=71) as AG/GG. For the same reason, we
combined GSTM1 and GSTT1 genotypes as a binary variable
GSTs that was coded as ‘‘null’’ if both GSTM1 and GSTT1 were
null and as ‘‘present’’ otherwise.
Confounders. In addition to the matched delivery date, we
considered family income, maternal age, education level, and
prepregnancy body mass index (BMI) as potential confounders.
We classified self-reported family income as low (,1500 Renminbi
[RMB, Chinese currency] monthly), middle (1500–4000 RMB
monthly), and high (.4000 RMB monthly). We calculated
prepregnancy BMI as self-reported prepregnancy weight in kg/
height in meter
2, and classified women into underweight
(BMI,18.5), normal (BMI 8.5–24.0), and overweight or obese
(BMI$24.0) according to WHO guideline for Asians [28].
Statistical Analyses
We first conducted Chi-square/t-test to examine the overall
characteristic balance between PTD case and control groups. Chi-
square test was adopted to test the associations between maternal
passive smoking during pregnancy, single gene polymorphism with
the risk of PTD, we then fitted multivariable logistic regression
models to estimate the odds ratios (OR) and their 95% confidence
intervals (CI), adjusting for potential confounders.
To examine whether the association between maternal passive
smoking and PTD could be modified by maternal CYP1A1 and
GSTs polymorphisms, we tested their interactions on multiplica-
tive scale. Specifically, we added the interaction terms ‘‘passive
smoking6gene polymorphism’’ (products) to the multivariable
logistic regression models which already included the main effect
terms for passive smoking and CYP1A1 and GSTs genotypes, as
well as the potential confounders. A significant departure of the
OR value for an interaction term from 1 indicated the existence of
interaction on a multiplicative scale. To better demonstrate joint
gene-passive smoking interaction, we also classified participants
into 8 exclusive groups by passive smoking status (yes vs. no),
CYP1A1 (‘‘wild’’ vs. ‘‘variant’’), and GSTs (‘‘present’’ vs. ‘‘null’’).
We set non-passive smoking mothers with low risk genotypes
(CYP1A1 ‘‘TT’’ or ‘‘AA’’+GSTs ‘‘present’’) as the reference group
Table 2. Associations of maternal passive smoking during pregnancy, CYP1A1, and GSTs genotypes with risks of spontaneous
PTD.
Case (n=198) Control (n=524) Crude OR (95% CI) OR
a (95%CI) P-value
N. (%) N. (%)
Passive smoking
during pregnancy
No 101(51.0) 369(70.4) 1 1
Yes 97(49.0) 155(29.6) 2.29 (1.63–3.20)
* 2.20 (1.56–3.12) 0.000
CYP1A1 Msp I
TT 73(36.9) 212(40.5) 1 1
TC/CC 125(63.1) 312(59.5) 1.16 (0.83–1.63) 1.15 (0.82–1.63) 0.418
CYP1A1 BsrD I
AA 95(48.0) 290(55.3) 1 1
AG/GG 103(52.0) 234(44.7) 1.34 (0.97–1.87) 1.30 (0.93–1.81) 0.133
GSTM1
Present 97(49.0) 275(52.5) 1 1
Null 101(51.0) 249(47.5) 1.15 (0.83–1.60) 1.12 (0.80–1.57) 0.515
GSTT1
Present 95(48.0) 241(46.0) 1 1
Null 103(52.0) 283(54.0) 0.92 (0.67–1.28) 0.97 (0.69–1.37) 0.877
GSTs
Present 137(69.2) 386(73.7) 1 1
Null 61(30.8) 138(26.3) 1.25 (0.87–1.78) 1.29 (0.89–1.87) 0.182
a.OR
a adjusted for family income, maternal age, education level and prepregnancy BMI.
b.GSTs ‘‘null’’ if both GSTM1 and GSTT1 ‘‘null’’, GSTs ‘‘present’’ if either GSTM1 or GSTT1 ‘‘present’’.
doi:10.1371/journal.pone.0049155.t002
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completed in SPSS 16.0 software (SPSS Inc, Chicago, Illinois,
USA). The statistical significance level was set to ,0.05 (two-
sided).
Results
Table 1 shows the characteristics of our study sample. Overall,
the PTD case and control groups were comparable in terms of
maternal age, marital status, socio-economic status, alcohol use
during pregnancy, prepregnancy BMI, and the child gender.
However, mothers in the case group had lower education level
(36.9% vs. 46.9% with college or higher degree), and were also
more likely to be parous (32.3% vs. 24.0%), when compared with
mothers in the control group.
Table 2 shows the overall associations (main effect) of maternal
passive smoking during pregnancy and single gene polymorphism
with risk of PTD. The proportion of passive smoking mothers in
the PTD group (49.0%) was much higher than those in the control
group (29.6%), and the adjusted OR was 2.20 (95% CI: 1.56–
3.12). However, the distribution of CYP1A1 Msp I, CYP1A1 BsrD
I, GSTM and GSTT1 genotypes were similar between the two
groups.
Table 3 shows the interactions between maternal passive
smoking during pregnancy and single gene loci polymorphism
on risk of PTD, after adjusting for potential confounders. Overall,
there was no significant interaction between maternal smoking
during pregnancy with any of the 4 selected gene loci (CYP1A1
Msp I, CYP1A1 BsrD I, GSTM1 and GSTT1) on multiplicative
scale.
Table 3. Interaction between maternal passive smoking during pregnancy and single genotype of CYP1A1 and GSTs on risk of
spontaneous PTD.
Passive
smoking Genotype Case(n=198) Control(n=524) OR
a(95%CI) P-value
N.(%) N.(%)
CYP1A1 Msp I
No TT 41 (20.7) 151 (28.8) 1
No TC/CC 60 (30.3) 218 (41.6) 0.96 (0.61–1.52) 0.876
Yes TT 32 (16.2) 61 (11.6) 1.75 (1.00–3.07)* 0.052
Yes TC/CC 65 (32.8) 94 (17.9) 2.42 (1.50–3.89)* 0.000
Interaction 1.44 (0.71–2.92) 0.319
CYP1A1 BsrD I
No AA 50 (25.3) 203 (38.7) 1
No AG/GG 51 (23.5) 166 (31.7) 1.18 (0.75–1.85) 0.483
Yes AA 45 (22.7) 87 (16.6) 1.98 (1.22–3.22)
* 0.007
Yes AG/GG 52 (26.3) 68 (13.0) 2.90 (1.78–4.72)
* 0.000
Interaction 1.24 (0.62–2.47) 0.541
GSTM1
No Present 49 (24.7) 195 (37.2) 1
No Null 52 (26.2) 174 (35.7) 1.15 (0.73–1.81) 0.519
Yes Present 48 (24.2) 80 (15.3) 2.30 (1.41–3.74) 0.001
Yes Null 49 (24.7) 75 (29.5) 2.43 (1.49–3.97) 0.000
Interaction 0.92 (0.46–1.83) 0.806
GSTT1
No Present 49 (24.7) 163 (31.1) 1
No Null 52 (26.2) 206 (39.3) 0.84 (0.53–1.33) 0.454
Yes Present 46 (23.2) 78 (14.9) 1.81 (1.10–2.98) 0.020
Yes Null 51 (25.8) 77 (14.7) 2.22 (1.37–3.62) 0.002
Interaction 1.46 (0.73–2.91) 0.286
GSTs
No Present 73 (36.9) 267 (51.0) 1
No Null 28 (14.1) 102 (19.5) 1.00 (0.60–1.66) 0.999
Yes Present 64 (32.3) 119 (22.7) 1.86 (1.24–2.81) 0.003
Yes Null 33 (16.7) 36 (6.9) 3.39 (1.95–5.91) 0.000
Interaction 1.83 (0.84–3.96) 0.126
a.OR
a adjusted for family income, maternal age, education level and prepregnancy BMI.
b.GSTs ‘‘null’’ if both GSTM1 and GSTT1 ‘‘null’’, GSTs ‘‘present’’ if either GSTM1 or GSTT1 ‘‘present’’.
c.% for distribution within the case and control groups respectively.
doi:10.1371/journal.pone.0049155.t003
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smoking during pregnancy and joint gene polymorphisms on risks
of PTD, after adjusted for potential confounders. Compared with
non-passive smoking women with CYP1A1 ‘‘TT’’ and GSTs
‘‘present’’, those passive smoking women with CYP1A1 ‘‘TC/
CC’’+ GSTs ‘‘null’’ had higher risk of PTD (OR=4.72 [95% CI:
2.28–9.77]), the interaction between passive smoking and
CYP1A1 ‘‘TC/CC’’+ GSTs ‘‘null’’ was statistically significant
(OR=2.66 [95% CI: 1.19–5.97; P-value: 0.017]) on multiplicative
scale (Table 4). Compared with non-passive smoking women with
CYP1A1 ‘‘AA’’ and GSTs ‘‘present’’, those passive smoking
women with CYP1A1 ‘‘AG/GG’’+ GSTs ‘‘null’’ had higher risk of
PTD (OR=7.01 [95% CI: 2.91–16.86]), the interaction between
passive smoking and CYP1A1 ‘‘AG/GG’’+ GSTs ‘‘null’’ was
statistically significant (OR=3.00 [95% CI: 1.17–7.74; P-value:
0.023]) on multiplicative scale (Table 5).
Discussion
In this case-control study among Chinese women, we examined
the interactions between maternal passive smoking during
pregnancy and genes (CYP1A1, GSTs) polymorphisms on the
risks of spontaneous preterm delivery. We confirmed that maternal
passive smoking was associated with higher risk of spontaneous
preterm delivery. In addition, this increased risk was more striking
for those women with the jointed genotype of CYP1A1‘‘AG/
GG’’+GSTs‘‘null’’.
We found that maternal passive smoking during pregnancy was
associated with more than two-fold risk of PTD, after adjusting for
a series of potential confounders. This estimate is very close to a
Table 4. Interaction between maternal passive smoking during pregnancy and joint genotype of CYP1A1 Msp I and GSTs on risk
of spontaneous PTD.
Passive smoking Genotype Case (n=198) Control (n=524) OR
a(95%CI) P-value
CYP1A1 Msp I GSTs N. (%) N. (%)
No TT Present 30 (15.2%) 110 (21.0%) 1
No TT Null 11 (5.6%) 41 (7.8%) 1.04 (0.47–2.29) 0.918
No TC/CC Present 43 (21.7%) 157 (30.0%) 0.98 (0.57–1.67) 0.947
No TC/CC Null 17 (8.6%) 61 (11.6%) 0.95 (0.47–1.93) 0.902
Yes TT Present 25 (12.6%) 45 (8.6%) 1.82 (0.95–3.48) 0.072
Yes TT Null 7 (3.5%) 16 (3.1%) 1.64 (0.61–4.41) 0.326
Yes TC/CC Present 39 (19.7%) 74 (14.1%) 1.85 (1.04–3.26) 0.035
Yes TC/CC Null 26 (13.1%) 20 (3.8%) 4.72 (2.28–9.77) 0.000
Interaction 2.66 (1.19–5.97) 0.017
a.OR
a adjusted for family income, maternal age, education level, prepregnancy BMI and CYP1A1 BsrD I genotype.
b.GSTs ‘‘null’’ if both GSTM1 and GSTT1 ‘‘null’’, GSTs ‘‘present’’ if either GSTM1 or GSTT1 ‘‘present’’.
c.% for distribution within the case and control groups respectively.
d.The variable of passive smoking+CYP1A1 Msp I+ GSTs with eight levels was set as dummy independent variable, and the first level as reference category.
doi:10.1371/journal.pone.0049155.t004
Table 5. Interaction between maternal passive smoking during pregnancy and joint genotype of CYP1A1 BsrD I and GSTs on risk
of spontaneous PTD.
Passive smoking Genotype Case (n=198) Control (n=524) OR
a(95%CI) P-value
CYP1A1 BsrD I GSTs N. (%) N. (%)
No AA Present 38 (19.2%) 149 (28.4%) 1
No AA Null 12 (6.1%) 54 (10.3%) 0.94 (0.45–1.95) 0.863
No AG/GG Present 35 (17.7%) 118 (22.5%) 1.14 (0.67–1.95) 0.636
No AG/GG Null 16 (8.1%) 48 (9.2%) 1.19 (0.59–2.42) 0.613
Yes AA Present 30 (15.2%) 61 (11.6%) 1.80 (1.01–3.22) 0.050
Yes AA Null 15 (7.6%) 26 (5.0%) 2.33 (1.11–4.89) 0.030
Yes AG/GG Present 34 (17.2%) 58 (11.1%) 2.17 (1.23–3.83) 0.008
Yes AG/GG Null 18 (9.1%) 10 (1.9%) 7.01 (2.91–16.86) 0.000
Interaction 3.00 (1.17–7.74) 0.023
a.OR
a adjusted for family income, maternal age, education level, prepregnancy BMI and CYP1A1 Msp I genotype.
b.GSTs ‘‘null’’ if both GSTM1 and GSTT1 ‘‘null’’, GSTs ‘‘present’’ if either GSTM1 or GSTT1 ‘‘present’’.
c.% for distribution within the case and control groups respectively.
d.The variable of passive smoking+CYP1A1 BsrD I + GSTs with eight levels was set as dummy independent variable, and the first level as reference category.
doi:10.1371/journal.pone.0049155.t005
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adds to the literature that maternal passive smoking during
pregnancy is a risk factor for PTD among women [30,31,32,33].
This suggests that pregnant women should try their best to avoid
passive smoking, which is especially important in developing
societies, such as China where 53% males (probably including
their husbands) are daily smokers [4].
There were limited evidences on interaction between CYP1A1,
GSTs polymorphisms and maternal active smoking during
pregnancy (no study on passive smoking so far) on the risk of
PTD. Our study showed that CYP1A1 m1 (Msp I) and m2 (BsrD
I) mutation and GSTs deletion alone, in the absence of maternal
passive smoking during pregnancy, did not increase the risk of
PTD. However, we found a significant synergy between maternal
passive smoking and CYP 1A1 ‘‘AG/GG’’ + GSTs ‘‘null’’
genotype, as well as between maternal passive smoking and
CYP1A1 ‘‘TC/CC’’ + GSTs ‘‘null’’ genotype; and noted that we
defined GSTs ‘‘null’’ if both GSTT1 and GSTM1 are null to
maximize the impact of GSTs null function. This suggests these
genetic risk factors may amplify the high risk of PTD associated
with passive smoking during pregnancy.
Preterm delivery is a complex phenotype with various
pathophysiological pathways, and more than 30 single nucleotide
polymorphisms (SNPs) have been found to be associated with PTD
or premature rupture of the membranes [34,35]. CYP1A1 and
GSTs genes are two of many pathways that control the conversion
of exogenous exposure [6]. So, it is likely that PTD cannot be
explained by the variation of single gene locus [6]. This may be
why we did not find interaction of passive smoking with single loci
of gene mutations (CYP1A1 or GSTs). However, we did find
significant interaction between joint genotypes of CYP1A1+GSTs
and passive smoking, which suggests CYP1A1 combined with
GSTs presents a stronger pathophysiological pathway through
which passive smoking increases the risk of PTD. This is
biologically plausible, because passive smoking mothers with
high-risk genotypes (i.e. CYP1A1 ‘‘AG/GG’’ or ‘‘TC/CC’’) may
have the higher-activity enzymes that metabolize cigarette toxins
such as PAHs, when GSTs detoxification function is null, higher
levels of PAH-DNA adducts and DNA strand breakage were
produced and accumulated in the maternal body. Moreover, the
activated adducts can cause the placental inflammatory reaction
and initiate the uterus contraction thus lead to PTD [36]. Our
finding is consistent with a previous study on maternal active
smoking done by Tsai et al. [17]. They found a very strong
interaction between maternal active smoking and the joint
genotypes (CYP1A1‘‘AG/GG’’+GSTT1 ‘‘null’’) in the risk of
PTD accompanied by histologic chorioamnionitis.
Study Strengths and Limitations
This study has several notable strengths. This is the first study
on interaction between maternal passive smoking during preg-
nancy and maternal metabolism genes (e.g. CYP1A1 and GSTs)
on the risk of PTD. Secondly, our combined use of self-report and
serum cotinine level can largely reduce misclassification of
maternal passive smoking due to recall bias and/or biomarker
measurement error. Finally, we excluded women with chronic
disease and medical induced PTD, which allowed us to more
accurately estimate the impact of passive smoking on spontaneous
PTD as well as its interaction with CYP1A1 and GSTs genes.
However, some limitations should be mentioned. Firstly, the case-
control design of our study could only provide suggestive but not
confirmative causality regarding the association between maternal
smoking during pregnancy and PTD. Secondly, there was
substantial uncertainty in our estimated associations due to the
relatively small sample size of PTD cases. Thirdly, although we
adjusted for maternal socio-demographics and prepregnancy BMI,
we could not control some other important confounders, such as
air pollution during pregnancy which could increase the risk of
preterm birth [37,38]. Finally, we could not distinguish the timing
(e.g. by trimester) of passive smoking during pregnancy.
Conclusion
In summary, we found maternal passive smoking during
pregnancy was associated with higher risk of spontaneous PTD.
The genotypes of CYP1A1 ‘‘AG/GG’’ or ‘‘TC/CC’’ + GSTs
‘‘null’’ seemed to amplify the risk of spontaneous PTD associated
with passive smoking during pregnancy. This novel finding has
important clinical and public health implications. It not only
contributes to better understanding the pathogenic pathways
through which maternal passive smoking increases risk of
spontaneous PTD, but also helps to identify vulnerable pregnant
women who are subject to high risk of spontaneous PTD due to
maternal passive smoking.
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